S146. EFFECT OF CLOZAPINE ON REGIONAL CEREBRAL BLOOD FLOW IN TREATMENT-RESISTANT SCHIZOPHRENIA

BACKGROUND: Approximately one-third of schizophrenia patients will not respond adequately to conventional antipsychotic treatment; termed treatment-resistant schizophrenia (TRS). The only antipsychotic recommended for this group is clozapine, which may have unique efficacy in improving residual symp...

Descripción completa

Detalles Bibliográficos
Autores principales: Sendt, Kyra-Verena, McQueen, Grant, Gillespie, Amy, MacCabe, James, Zelaya, Fernando, Egerton, Alice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888012/
http://dx.doi.org/10.1093/schbul/sby018.933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888012/
http://dx.doi.org/10.1093/schbul/sby018.933

Ejemplares similares